(Q67743311)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735522%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

title

Oral bile acid treatment and the patient with Zellweger syndrome (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735522%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

Oral bile acid treatment and the patient with zellweger syndrome (English)

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150206

12 November 2022

1 reference

1 reference

K. D. Setchell

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735522

12 November 2022

P. Bragetti

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735522

12 November 2022

L. Zimmer-Nechemias

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735522

12 November 2022

C. Daugherty

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735522

12 November 2022

M. A. Pelli

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735522

12 November 2022

R. Vaccaro

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735522

12 November 2022

G. Gentili

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735522

12 November 2022

E. Distrutti

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735522

12 November 2022

G. Dozzini

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735522

12 November 2022

A. Morelli

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1735522

12 November 2022

language of work or name

English

0 references

publication date

1 February 1992

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735522%20AND%20SRC:MED&resulttype=core&format=json

full work available at URL

17 September 2019

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fhep.1840150206

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150206

https://onlinelibrary.wiley.com/doi/full/10.1002/hep.1840150206

12 November 2022

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150206

12 November 2022

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735522%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

volume

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735522%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

issue

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735522%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

page(s)

198-207

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735522%20AND%20SRC:MED&resulttype=core&format=json

Peroxisomal and mitochondrial defects in the cerebro-hepato-renal syndrome

17 September 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

A fatty acyl-CoA oxidizing system in rat liver peroxisomes; enhancement by clofibrate, a hypolipidemic drug

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Zellweger syndrome: biochemical and morphological studies on two patients treated with clofibrate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Unsuccessful attempts to induce peroxisomes in two cases of Zellweger disease by treatment with clofibrate

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Response of hepatic microbodies to a hypolipidemic agent, ethyl chlorophenoxyisobutyrate (CPIB)

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Familial giant cell hepatitis associated with synthesis of 3 beta, 7 alpha-dihydroxy-and 3 beta,7 alpha, 12 alpha-trihydroxy-5-cholenoic acids

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Delta 4-3-oxosteroid 5 beta-reductase deficiency described in identical twins with neonatal hepatitis. A new inborn error in bile acid synthesis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Treatment of chronic liver disease caused by 3 beta-hydroxy-delta 5-C27-steroid dehydrogenase deficiency with chenodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Serum bile acid analysis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

A rapid method for the quantitative extraction of bile acids and their conjugates from serum using commercially available reverse-phase octadecylsilane bonded silica cartridges

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Inborn errors of bile acid synthesis.

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Rapid diagnosis of Zellweger syndrome and infantile Refsum's disease by fast atom bombardment--mass spectrometry of urine bile salts

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Determination of pipecolic acid in urine and plasma by isotope dilution mass fragmentography

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Different clinical presentation of gastroesophageal reflux in twins

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Ursodeoxycholic acid in the treatment of cholesterol cholelithiasis. part I

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Determination of cholesteryl sulphate by isotope dilution-mass spectrometry for diagnosis of steroid sulphatase deficiency

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Bile acid therapies applied to patients suffering from cerebrotendinous xanthomatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Chenodeoxycholic acid inhibits increased cholesterol and cholestanol synthesis in patients with cerebrotendinous Xanthomatosis

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Long-term treatment of cerebrotendinous xanthomatosis with chenodeoxycholic acid

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Abnormalities of bile acids in serum and bile from patients with myotonic muscular dystrophy

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Treatment with ursodeoxycholic acid renders children with biliary atresia suitable for liver transplantation

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Steatorrhoea in cirrhosis: effect of ursodeoxycholic acid administration

1 reference

https://api.crossref.org/works/10.1002%2FHEP.1840150206

7 January 2021

Bulletin of the Johns Hopkins Hospital

1

114

402

Bowen

1964

1 reference

https://api.crossref.org/works/10.1002/HEP.1840150206

12 November 2022

Identifiers

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:1735522%20AND%20SRC:MED&resulttype=core&format=json

17 September 2019

1 reference